Suppr超能文献

探索白杨素周围的化学空间,开发新型血管钙通道 1.2 阻滞剂,有望成为血管舒张剂。

Exploring the chemical space around chrysin to develop novel vascular Ca1.2 channel blockers, promising vasorelaxant agents.

机构信息

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende, Italy.

Department of Biotechnologies, Chemistry and Pharmacy, University of Siena, Siena, Italy.

出版信息

Arch Pharm (Weinheim). 2024 Nov;357(11):e2400536. doi: 10.1002/ardp.202400536. Epub 2024 Sep 6.

Abstract

The flavonoid chrysin is an effective vascular Ca1.2 channel blocker. The aim of this study was to explore the chemical space around chrysin to identify the structural features that can be modified to develop novel and more effective blockers. Four derivatives (Chrysin 1-4) were synthesised and a functional, electrophysiology and molecular docking approach was pursued to assess their binding mode to Ca1.2 channels and their activity in vascular preparations. Methylation of the 5- and 7-OH of the chrysin backbone caused a marked reduction of the Ca antagonistic potency and efficacy. However, C-8 derivatives showed biophysical features similar to those of the parent compound and, like nicardipine, bound with high affinity to and stabilised the Ca1.2 channel in its inactivated state. The vasorelaxant effects of the four derivatives appeared vessel-specific, addressing the molecules' derivatization towards different targets. In conclusion, the scaffold of chrysin may be considered a valuable starting point for the development of innovative vascular Ca1.2 channel blockers.

摘要

黄酮类化合物白杨素是一种有效的血管 Ca1.2 通道阻滞剂。本研究旨在探索白杨素周围的化学空间,确定可修饰的结构特征,以开发新型、更有效的阻滞剂。合成了四个衍生物(Chrysin 1-4),并采用功能、电生理学和分子对接方法来评估它们与 Ca1.2 通道的结合模式及其在血管制剂中的活性。白杨素骨架的 5-和 7-OH 甲基化导致 Ca 拮抗活性和效能显著降低。然而,C-8 衍生物表现出与母体化合物相似的生物物理特征,并且与尼卡地平一样,与失活状态的 Ca1.2 通道高亲和力结合并稳定该通道。这四个衍生物的血管舒张作用表现出血管特异性,针对分子的不同靶点进行了衍生化。总之,白杨素的支架可以被认为是开发新型血管 Ca1.2 通道阻滞剂的有价值的起点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验